The Center for Global Cancer Medicine is dedicated to influencing worldwide policies about cancer care, particularly to benefit those in under-resourced countries. Through symposia, publications, and collaborations, the Center addresses the following facts about cancer around the world:
Thanks to the work of Lawrence Shulman, MD, Presidential Scholar of the Center for Global Cancer Medicine, 22 cancer drugs have been added to the World Health Organization's (WHO) List of Essential Medicines. Dr. Shulman and colleagues assembled more than 90 oncologists from around the world, and led the process of deciding which cancer drugs should be recommended for inclusion. Multiple protocols were authored or peer-reviewed by 15 Dana-Farber oncologists.
See the full application
For the past several years, the United States National Cancer Institute (NCI) Center for Global Health has hosted a satellite meeting during the Annual Conference of the Consortium of Universities for Global Health. The NCI invited the Center for Global Cancer Medicine to co-host the event in Boston in March 2015. This meeting brought oncologists from far and wide, providing an opportunity for networking in Boston, presentation of abstracts, and promoting case-based learning.
Dr. Larry Shulman was Guest-Editor of a Special Issue devoted entirely to global cancer medicine, in the
Journal of Clinical Oncology
Appointments and Second Opinions